Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : wla(warner lambert) -- Ignore unavailable to you. Want to Upgrade?

To: Zoltan! who wrote (146)	12/5/1997 3:50:00 PM
From: Ted Downs	Read Replies (2) \| Respond to of 942

Duncan, Nice to see an ethical company rewarded for putting safety above profits, isn't it? Then I understand you're saying that Warner Lambert is an unethical company is that correct? Also, by your implications you can also include the FDA with your statement is that correct? Ted

To: Zoltan! who wrote (146)	12/5/1997 4:05:00 PM
From: Richard Cohen	Respond to of 942

Duncan- Don't you think Glaxo has it's own agenda in all this?(like producing their own drug in this class) I personally think this is overkill and the drug will not be pulled off the market. Many drugs were released needing increased surviellance initially which was then decreased as time proved these drugs safe(ie. Pravacol, Prilosec, etc) I don't think there are any increase in adverse reactions than were found in FDA trials in U.S. I can't speak for other countries.BTW, how's your supply of spice? Rich